$NHI
National Health Investors Inc Stock $nhi

$nhi Overview Financials Valuation SEC Filings Company Website

2019 Q1 Form 10-Q Financial Statement

#000087786019000038 Filed on May 07, 2019

Income Statement

Concept	2019 Q1	2018 Q1
Revenue	$76.11M	$72.75M
YoY Change	4.62%	9.58%
Cost Of Revenue	$1.090M
YoY Change
Gross Profit	$75.02M
YoY Change
Gross Profit Margin	98.57%
Selling, General & Admin	$4.830M	$4.630M
YoY Change	4.32%	4.51%
% of Gross Profit	6.44%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$18.49M	$17.34M
YoY Change	6.67%	7.38%
% of Gross Profit	24.65%
Operating Expenses	$40.43M	$33.58M
YoY Change	20.41%	4.16%
Operating Profit	$35.68M	$39.17M
YoY Change	-8.91%	14.73%
Interest Expense	$13.52M	$11.61M
YoY Change	16.39%	-0.4%
% of Operating Profit	37.89%	29.65%
Other Income/Expense, Net
YoY Change
Pretax Income	$35.68M	$38.43M
YoY Change	-7.16%	-13.11%
Income Tax
% Of Pretax Income
Net Earnings	$35.68M	$38.43M
YoY Change	-7.16%	-13.11%
Net Earnings / Revenue	46.88%	52.83%
Basic Earnings Per Share	$0.83	$0.93
Diluted Earnings Per Share	$0.83	$0.92
COMMON SHARES
Basic Shares Outstanding	42.83M shares	41.53M shares
Diluted Shares Outstanding	43.13M shares	41.58M shares

Balance Sheet

Concept	2019 Q1	2018 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$5.200M	$3.200M
YoY Change	62.5%	-43.86%
Cash & Equivalents	$5.177M	$3.230M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables	$2.900M	$9.000M
Other Receivables	$75.10M	$102.0M
Total Short-Term Assets	$83.20M	$114.2M
YoY Change	-27.15%	33.72%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.435B	$2.286B
YoY Change	6.5%	0.79%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$14.10M	$8.200M
YoY Change	71.95%	100.0%
Total Long-Term Assets	$2.723B	$2.445B
YoY Change	11.36%	0.6%
TOTAL ASSETS
Total Short-Term Assets	$83.20M	$114.2M
Total Long-Term Assets	$2.723B	$2.445B
Total Assets	$2.806B	$2.559B
YoY Change	9.64%	1.73%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$21.40M	$16.50M
YoY Change	29.7%	-23.61%
Accrued Expenses	$1.200M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$78.60M	$79.30M
YoY Change	-0.88%	-4.46%
LONG-TERM LIABILITIES
Long-Term Debt	$1.287B	$1.160B
YoY Change	10.95%	1.27%
Other Long-Term Liabilities	$24.60M
YoY Change
Total Long-Term Liabilities	$1.312B	$1.160B
YoY Change	13.07%	1.27%
TOTAL LIABILITIES
Total Short-Term Liabilities	$78.60M	$79.30M
Total Long-Term Liabilities	$1.312B	$1.160B
Total Liabilities	$1.390B	$1.240B
YoY Change	12.16%	0.88%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock	$1.407B	$1.289B
YoY Change	9.15%	2.72%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.416B	$1.320B
YoY Change
Total Liabilities & Shareholders Equity	$2.806B	$2.559B
YoY Change	9.64%	1.73%

Cashflow Statement

Concept	2019 Q1	2018 Q1
OPERATING ACTIVITIES
Net Income	$35.68M	$38.43M
YoY Change	-7.16%	-13.11%
Depreciation, Depletion And Amortization	$18.49M	$17.34M
YoY Change	6.67%	7.38%
Cash From Operating Activities	$73.84M	$48.88M
YoY Change	51.07%	0.41%
INVESTING ACTIVITIES
Capital Expenditures	-$50.10M	-$14.40M
YoY Change	247.92%	-87.8%
Acquisitions
YoY Change
Other Investing Activities	-$14.90M	-$5.200M
YoY Change	186.54%	116.67%
Cash From Investing Activities	-$65.04M	-$19.59M
YoY Change	232.07%	-83.74%
FINANCING ACTIVITIES
Cash Dividend Paid	$42.70M	$39.46M
YoY Change	8.22%	10.02%
Common Stock Issuance & Retirement, Net	$35.91M	-$56.00K
YoY Change	-64230.36%	-100.07%
Debt Paid & Issued, Net	$296.0K
YoY Change
Cash From Financing Activities	-$3.156M	-$28.76M
YoY Change	-89.02%	-139.6%
NET CHANGE
Cash From Operating Activities	$73.84M	$48.88M
Cash From Investing Activities	-$65.04M	-$19.59M
Cash From Financing Activities	-$3.156M	-$28.76M
Net Change In Cash	$5.642M	$536.0K
YoY Change	952.61%	-37.16%
FREE CASH FLOW
Cash From Operating Activities	$73.84M	$48.88M
Capital Expenditures	-$50.10M	-$14.40M
Free Cash Flow	$123.9M	$63.28M
YoY Change	95.86%	-62.04%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2019Q1	dei	Amendment Flag AmendmentFlag	false
CY2019Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2019Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2019Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
CY2019Q1	dei	Document Period End Date DocumentPeriodEndDate	2019-03-31
CY2019Q1	dei	Document Type DocumentType	10-Q
CY2019Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000877860
CY2019Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	43199318	shares
CY2019Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2019Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2019Q1	nhi	Debt Instrument Variable Rate Basis Minimum DebtInstrumentVariableRateBasisMinimum	249.45
CY2019Q1	dei	Entity Registrant Name EntityRegistrantName	NATIONAL HEALTH INVESTORS INC
CY2019Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2018Q4	nhi	Accounts Receivableand Other Assets AccountsReceivableandOtherAssets	6381000	USD
CY2019Q1	nhi	Accounts Receivableand Other Assets AccountsReceivableandOtherAssets	2864000	USD
CY2018Q1	nhi	Amortization Of Financing Costs Exclusive Of Amounts Written Off AmortizationOfFinancingCostsExclusiveOfAmountsWrittenOff	835000	USD
CY2019Q1	nhi	Amortization Of Financing Costs Exclusive Of Amounts Written Off AmortizationOfFinancingCostsExclusiveOfAmountsWrittenOff	893000	USD
CY2018Q1	nhi	Changein Accounts Payable Investmentsin Real Estate Acquisition ChangeinAccountsPayableInvestmentsinRealEstateAcquisition	0	USD
CY2019Q1	nhi	Changein Accounts Payable Investmentsin Real Estate Acquisition ChangeinAccountsPayableInvestmentsinRealEstateAcquisition	1178000	USD
CY2018Q1	nhi	Changein Accounts Payable Investmentsin Real Estate Construction ChangeinAccountsPayableInvestmentsinRealEstateConstruction	290000	USD
CY2019Q1	nhi	Changein Accounts Payable Investmentsin Real Estate Construction ChangeinAccountsPayableInvestmentsinRealEstateConstruction	-1048000	USD
CY2018Q1	nhi	Changein Other Assets Investmentsin Real Estate ChangeinOtherAssetsInvestmentsinRealEstate	0	USD
CY2019Q1	nhi	Changein Other Assets Investmentsin Real Estate ChangeinOtherAssetsInvestmentsinRealEstate	176000	USD
CY2018Q1	nhi	Changein Straightline Rent Receivable Investmentsin Real Estate ChangeinStraightlineRentReceivableInvestmentsinRealEstate	0	USD
CY2019Q1	nhi	Changein Straightline Rent Receivable Investmentsin Real Estate ChangeinStraightlineRentReceivableInvestmentsinRealEstate	38000000	USD
CY2018Q4	nhi	Credit Facility Current Revolving Borrowing Capacity CreditFacilityCurrentRevolvingBorrowingCapacity	550000000	USD
CY2018Q4	nhi	Debt Instrument Variable Rate Basis Minimum DebtInstrumentVariableRateBasisMinimum	250.269
CY2018Q1	nhi	Franchise Excise And Other Taxes FranchiseExciseAndOtherTaxes	346000	USD
CY2019Q1	nhi	Franchise Excise And Other Taxes FranchiseExciseAndOtherTaxes	545000	USD
CY2018Q1	nhi	Lessee Payment To Acquire Purchase Option LesseePaymentToAcquirePurchaseOption	1275000	USD
CY2019Q1	nhi	Lessee Payment To Acquire Purchase Option LesseePaymentToAcquirePurchaseOption	0	USD
CY2018Q1	nhi	Lessor Property Costs Paid From Tenant Escrow LessorPropertyCostsPaidFromTenantEscrow	0	USD
CY2019Q1	nhi	Lessor Property Costs Paid From Tenant Escrow LessorPropertyCostsPaidFromTenantEscrow	1090000	USD
CY2018Q1	nhi	Loanand Lease Lossesand Recoveries Net LoanandLeaseLossesandRecoveriesNet	0	USD
CY2019Q1	nhi	Loanand Lease Lossesand Recoveries Net LoanandLeaseLossesandRecoveriesNet	2500000	USD
CY2019Q1	nhi	Maximum Commitment For All Active Development Projects MaximumCommitmentForAllActiveDevelopmentProjects	45630000	USD
CY2019Q1	nhi	Nonemployeedirectorannualstockgrants Nonemployeedirectorannualstockgrants	25000	shares
CY2019Q1	nhi	Nonportfolio Assets Original Cost NonportfolioAssetsOriginalCost	2471000	USD
CY2019Q1	nhi	Notes Receivable Funding Commitment NotesReceivableFundingCommitment	120822000	USD
CY2019Q1	nhi	Number Of Health Care Properties Related To Mortgage Notes Receivables NumberOfHealthCarePropertiesRelatedToMortgageNotesReceivables	12	properties
CY2019Q1	nhi	Number Of Lessees NumberOfLessees	30
CY2018Q1	nhi	Paymentsof Tenant Lease Incentives PaymentsofTenantLeaseIncentives	0	USD
CY2019Q1	nhi	Paymentsof Tenant Lease Incentives PaymentsofTenantLeaseIncentives	1250000	USD
CY2019Q1	nhi	Portionof Debt Instrument Not Fixedwith Interest Rate Derivative PortionofDebtInstrumentNotFixedwithInterestRateDerivative	100000000	USD
CY2019Q1	nhi	Real Estate Investment Property Portfolio Assets RealEstateInvestmentPropertyPortfolioAssets	2900846000	USD
CY2019Q1	nhi	Real Estate Investments During The Period RealEstateInvestmentsDuringThePeriod	90200000	USD
CY2019Q1	nhi	Remaining Unfunded Development Commitment RemainingUnfundedDevelopmentCommitment	23881000	USD
CY2019Q1	nhi	Variable Interest Entity Number Of Entities Not Primary Beneficiary VariableInterestEntityNumberOfEntitiesNotPrimaryBeneficiary	6	properties
CY2018Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	19890000	USD
CY2019Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	22532000	USD
CY2018Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	451483000	USD
CY2019Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	468562000	USD
CY2018Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1299000	USD
CY2019Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	342000	USD
CY2018Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1369919000	USD
CY2019Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1406822000	USD
CY2018Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1425000	USD
CY2019Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2001000	USD
CY2018	us-gaap	Allowance For Loan And Lease Losses Write Offs AllowanceForLoanAndLeaseLossesWriteOffs	0	USD
CY2019Q1	us-gaap	Allowance For Loan And Lease Losses Write Offs AllowanceForLoanAndLeaseLossesWriteOffs	0.00	USD
CY2018Q1	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	552000	USD
CY2019Q1	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	119000	USD
CY2018Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1069000	USD
CY2019Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1263000	USD
CY2018Q1	us-gaap	Amortization Of Lease Incentives AmortizationOfLeaseIncentives	63000	USD
CY2019Q1	us-gaap	Amortization Of Lease Incentives AmortizationOfLeaseIncentives	168000	USD
CY2018Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	118639	shares
CY2019Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	17415	shares
CY2018Q4	us-gaap	Assets Assets	2750570000	USD
CY2019Q1	us-gaap	Assets Assets	2806268000	USD
CY2018Q1	us-gaap	Cash Cash	3230000	USD
CY2019Q1	us-gaap	Cash Cash	5177000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4659000	USD
CY2019Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5177000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8075000	USD
CY2018Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8611000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9912000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15554000	USD
CY2018Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	536000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	5642000	USD
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.00
CY2019Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.05
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2019Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000	shares
CY2019Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000	shares
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	42700411	shares
CY2019Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43199318	shares
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	42700411	shares
CY2019Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	43199318	shares
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	427000	USD
CY2019Q1	us-gaap	Common Stock Value CommonStockValue	432000	USD
CY2018Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	40354000	USD
CY2019Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	34722000	USD
CY2018Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	16643000	USD
CY2019Q1	us-gaap	Construction In Progress Gross ConstructionInProgressGross	19810000	USD
CY2018Q4	us-gaap	Convertible Debt ConvertibleDebt	118609000	USD
CY2019Q1	us-gaap	Convertible Debt ConvertibleDebt	118802000	USD
CY2018Q4	us-gaap	Cumulative Earnings Deficit CumulativeEarningsDeficit	18068000	USD
CY2019Q1	us-gaap	Cumulative Earnings Deficit CumulativeEarningsDeficit	8388000	USD
CY2019Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1298974000	USD
CY2019Q1	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	69.11
CY2019Q1	us-gaap	Debt Instrument Convertible Conversion Ratio1 DebtInstrumentConvertibleConversionRatio1	14.47
CY2019Q1	us-gaap	Debt Instrument Convertible If Converted Value In Excess Of Principal DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal	16390000	USD
CY2019Q1	us-gaap	Debt Instrument Convertible Number Of Equity Instruments DebtInstrumentConvertibleNumberOfEquityInstruments	1736340	shares
CY2019Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	2497000	USD
CY2018Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	1281675000	USD
CY2019Q1	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	1287205000	USD
CY2018Q4	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	105620000	USD
CY2019Q1	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	75123000	USD
CY2018Q4	us-gaap	Deferred Revenue DeferredRevenue	5954000	USD
CY2019Q1	us-gaap	Deferred Revenue DeferredRevenue	24550000	USD
CY2018Q1	us-gaap	Depreciation Depreciation	17335000	USD
CY2019Q1	us-gaap	Depreciation Depreciation	18491000	USD
CY2018Q4	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	1297000	USD
CY2019Q1	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	339000	USD
CY2018Q1	us-gaap	Derivative Instruments Loss Reclassified From Accumulated Oci Into Income Effective Portion DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion	276000	USD
CY2019Q1	us-gaap	Derivative Instruments Loss Reclassified From Accumulated Oci Into Income Effective Portion DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion	292000	USD
CY2019Q1	us-gaap	Development In Process DevelopmentInProcess	21749000	USD
CY2018Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	42700000	USD
CY2019Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	45359000	USD
CY2018Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.93
CY2019Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.83
CY2018Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.92
CY2019Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.83
CY2019Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	2298000	USD
CY2018Q4	us-gaap	Escrow Deposit EscrowDeposit	8208000	USD
CY2019Q1	us-gaap	Escrow Deposit EscrowDeposit	8208000	USD
CY2018Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-738000	USD
CY2019Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2018Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4170000	USD
CY2019Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4014000	USD
CY2018Q4	us-gaap	Incentive To Lessee IncentiveToLessee	7456000	USD
CY2019Q1	us-gaap	Incentive To Lessee IncentiveToLessee	8538000	USD
CY2018Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	585000	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1597000	USD
CY2018Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	56000	USD
CY2019Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	16322000	USD
CY2018Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3876000	USD
CY2019Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2961000	USD
CY2018Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
CY2019Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	223513	shares
CY2018Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	44722	shares
CY2019Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	75695	shares
CY2018Q1	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	24000	USD
CY2019Q1	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	157000	USD
CY2018Q1	us-gaap	Interest Expense InterestExpense	11614000	USD
CY2019Q1	us-gaap	Interest Expense InterestExpense	13518000	USD
CY2018Q1	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	10527000	USD
CY2019Q1	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	13074000	USD
CY2018Q1	us-gaap	Interest Income Operating InterestIncomeOperating	3493000	USD
CY2019Q1	us-gaap	Interest Income Operating InterestIncomeOperating	5154000	USD
CY2018Q1	us-gaap	Interest Paid InterestPaid	9904000	USD
CY2019Q1	us-gaap	Interest Paid InterestPaid	11901000	USD
CY2019Q1	us-gaap	Interest Rate Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months Net InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet	881000	USD
CY2018Q4	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	2599526000	USD
CY2019Q1	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	2676127000	USD
CY2018Q4	us-gaap	Land Land	202196000	USD
CY2019Q1	us-gaap	Land Land	207380000	USD
CY2018Q1	us-gaap	Legal Fees LegalFees	111000	USD
CY2019Q1	us-gaap	Legal Fees LegalFees	270000	USD
CY2019Q1	us-gaap	Lessor Operating Lease Renewal Term LessorOperatingLeaseRenewalTerm	P5Y0M0D
CY2018Q4	us-gaap	Liabilities Liabilities	1360857000	USD
CY2019Q1	us-gaap	Liabilities Liabilities	1390284000	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2750570000	USD
CY2019Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2806268000	USD
CY2018Q4	us-gaap	Line Of Credit LineOfCredit	84000000	USD
CY2019Q1	us-gaap	Line Of Credit LineOfCredit	89000000	USD
CY2019Q1	us-gaap	Line Of Credit Facility Unused Capacity Commitment Fee Percentage LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage	20
CY2019Q1	us-gaap	Loans And Leases Receivable Commitments Fixed Rates LoansAndLeasesReceivableCommitmentsFixedRates	311700000	USD
CY2018Q4	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	246111000	USD
CY2019Q1	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	257481000	USD
CY2019Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Rolling Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths	1196000	USD
CY2019Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive	358513000	USD
CY2019Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive	351390000	USD
CY2019Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour	465340000	USD
CY2019Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo	1244000	USD
CY2019Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	121291000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-28755000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3156000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-19586000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-65039000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	48877000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	73837000	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	38432000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	35679000	USD
CY2019Q1	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	220	properties
CY2019Q1	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	33
CY2018Q1	us-gaap	Operating Expenses OperatingExpenses	33576000	USD
CY2019Q1	us-gaap	Operating Expenses OperatingExpenses	40428000	USD
CY2018Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	39170000	USD
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	35679000	USD
CY2019Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1176000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	3031002000	USD
CY2019Q1	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	2939208000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	304887000	USD
CY2019Q1	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	192261000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	252602000	USD
CY2019Q1	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	253653000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	258245000	USD
CY2019Q1	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	259674000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	255806000	USD
CY2019Q1	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	257610000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	254321000	USD
CY2019Q1	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	256991000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	1705141000	USD
CY2019Q1	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	1719019000	USD
CY2018Q1	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	69253000	USD
CY2019Q1	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	70953000	USD
CY2018Q4	us-gaap	Other Assets OtherAssets	27298000	USD
CY2019Q1	us-gaap	Other Assets OtherAssets	29987000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1922000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-957000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax	-276000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax	292000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	1646000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	-665000	USD
CY2018Q1	us-gaap	Other Noncash Income OtherNoncashIncome	436000	USD
CY2019Q1	us-gaap	Other Noncash Income OtherNoncashIncome	548000	USD
CY2018Q1	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	1812000	USD
CY2019Q1	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	4215000	USD
CY2018Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2019Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	67000	USD
CY2018Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	39456000	USD
CY2019Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	42700000	USD
CY2018Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	USD
CY2019Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1006000	USD
CY2018Q1	us-gaap	Payments To Acquire Mortgage Notes Receivable PaymentsToAcquireMortgageNotesReceivable	5905000	USD
CY2019Q1	us-gaap	Payments To Acquire Mortgage Notes Receivable PaymentsToAcquireMortgageNotesReceivable	11002000	USD
CY2018Q1	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	14404000	USD
CY2019Q1	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	50122000	USD
CY2018Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	-56000	USD
CY2019Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	35913000	USD
CY2018Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	56000000	USD
CY2019Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	95000000	USD
CY2018Q1	us-gaap	Proceeds From Sale And Collection Of Mortgage Notes Receivable ProceedsFromSaleAndCollectionOfMortgageNotesReceivable	2535000	USD
CY2019Q1	us-gaap	Proceeds From Sale And Collection Of Mortgage Notes Receivable ProceedsFromSaleAndCollectionOfMortgageNotesReceivable	300000	USD
CY2019Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2903317000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2818365000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2366882000	USD
CY2019Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2434755000	USD
CY2018Q4	us-gaap	Real Estate Heldforsale RealEstateHeldforsale	0	USD
CY2019Q1	us-gaap	Real Estate Heldforsale RealEstateHeldforsale	3745000	USD
CY2018Q1	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	285000	USD
CY2019Q1	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	296000	USD
CY2018Q1	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	29958000	USD
CY2019Q1	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	USD
CY2018Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	15000000	USD
CY2019Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	90000000	USD
CY2018Q1	us-gaap	Restricted Cash RestrictedCash	5381000	USD
CY2018Q4	us-gaap	Restricted Cash RestrictedCash	5253000	USD
CY2019Q1	us-gaap	Restricted Cash RestrictedCash	10377000	USD
CY2018Q1	us-gaap	Revenues Revenues	72746000	USD
CY2019Q1	us-gaap	Revenues Revenues	76107000	USD
CY2018Q4	us-gaap	Security Deposit Liability SecurityDepositLiability	10638000	USD
CY2019Q1	us-gaap	Security Deposit Liability SecurityDepositLiability	10638000	USD
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.065
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.055
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.194
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.186
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0239
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0250
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	949160	shares
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	678997	shares
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	4.49
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	6.17
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	859182	shares
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1404182	shares
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	920346	shares
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1169516	shares
CY2018Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y10M24D
CY2019Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y10M24D
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	1389713000	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	1415984000	USD
CY2018Q1	us-gaap	Straight Line Rent StraightLineRent	5962000	USD
CY2019Q1	us-gaap	Straight Line Rent StraightLineRent	5228000	USD
CY2018Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	9884000	USD
CY2019Q1	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	9272000	USD
CY2019Q1	us-gaap	Unsecured Debt UnsecuredDebt	400000000	USD
CY2018Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	41532154	shares
CY2019Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	42825824	shares
CY2018Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41576876	shares
CY2019Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43125032	shares
CY2018Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41532154	shares
CY2019Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	42825824	shares
CY2019Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Reclassifications</font><font style="font-family:inherit;font-size:10pt;"> - We have reclassified certain balances where necessary to conform the presentation of prior periods to the current period. These reclassifications had no effect on previously reported net income.</font></div></div>
CY2019Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates -</font><font style="font-family:inherit;font-size:10pt;"> The preparation of financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates</font></div></div>

Files In Submission

Name	View Source	Status
0000877860-19-000038-index-headers.html	Edgar Link	pending
0000877860-19-000038-index.html	Edgar Link	pending
0000877860-19-000038.txt	Edgar Link	pending
0000877860-19-000038-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
nhi-20190331.xml	Edgar Link	completed
nhi-20190331.xsd	Edgar Link	pending
nhi-20190331_cal.xml	Edgar Link	unprocessable
nhi-20190331_def.xml	Edgar Link	unprocessable
nhi-20190331_lab.xml	Edgar Link	unprocessable
nhi-20190331_pre.xml	Edgar Link	unprocessable
nhi-3312019x10qex311.htm	Edgar Link	pending
nhi-3312019x10qex312.htm	Edgar Link	pending
nhi-3312019x10qex32.htm	Edgar Link	pending
nhi-3312019x10qq1.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NHI
National Health Investors Inc Stock $nhi

2019 Q1 Form 10-Q Financial Statement

#000087786019000038 Filed on May 07, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NHI National Health Investors Inc Stock $nhi

2019 Q1 Form 10-Q Financial Statement

#000087786019000038 Filed on May 07, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NHI
National Health Investors Inc Stock $nhi